Kneat.com (KSI) Q4 2024 earnings summary

Executive summary

• Achieved strong revenue and operating margin growth in Q4 and full-year 2024, with record ARR additions and customer expansions across multiple regions and industries.

• Expanded customer base with significant deals in life sciences, pharma, medical devices, and engineering sectors, including partnerships with ALTEN, Capgemini, and Körber.

• Enhanced operational efficiency and product capabilities, including AI integration and formalization of the partner program.

• EBITDA turned positive: $1.1M in Q4 and $5.6M for the year; Adjusted EBITDA was $2.6M in Q4 and $7.0M for the year.

• Net Revenue Retention Rate reached 151% for 2024, reflecting strong customer expansion.

Financial highlights

• Q4 revenue grew 40% year-over-year to $13.7M; full-year revenue up 43% to $48.9M.

• SaaS revenue increased 41% year-over-year in Q4 to $12.5M; full-year SaaS revenue up 48% to $44.6M.

• Annual recurring revenue (ARR) reached $59.7M, up 60% year-over-year.

• Gross profit for Q4 was $10.4M, up 48% year-over-year; full-year gross profit up 59% to $36.8M.

• Net loss for 2024 was $7.7M, improved from $14.5M in 2023; loss per share was $0.09 vs. $0.19.

Outlook and guidance

• Confident in achieving 2025 goals: more new customer additions, increased digital validation adoption, and team expansion.

• Optimistic about pipeline quality and expects continued strong ARR growth in 2025, supported by strategic sales and R&D hires.

• Free cash flow breakeven expected by late 2025 or into 2026, with positive cash flow in the first half of 2025.

• Entered 2025 with a solid balance sheet and plans to invest in growth and product innovation.

• Business momentum continues with new partnerships and customer wins announced in early 2025.